Form 4 for RVMD Revolution Medicines, Inc.
Accepted 2023-06-22 00:00:00 ET · period of report 2023-06-20 · accession 0001610717-23-000194 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-22 | 2023-06-20 | RVMD | Horn Margaret A | COO | S - Sale | $24.89 | -2,102 | 99.5K | -2% | -$52.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-20 | S | D | 2,102 | $24.89 | 99,474 | D | — | — | (F2) Includes 1,514 shares acquired under the Issuer's Employee Stock Purchase Plan on May 31, 2023. (F3) Includes 70,738 RSUs. |